Skip to main content

Table 3 Levels of laboratory parameters in different METAVIR fibrosis stages in patients with hepatitis C virus mono-infection and HCV/Helicobacter pylori (H. pylori) co-infection

From: Prevalence of Helicobacter pylori infection in patients with chronic hepatitis C

Variablesa

No fibrosis (F0)

Liver fibrosis (F1‑F3)

Cirrhosis (F4)

Group Ib (n = 63)

Group IIb (n = 32)

*P value

Group Ib (n = 50)

Group IIb (n = 40)

*P value

Group Ib (n = 18)

Group IIb (n = 46)

*P value

Age (year)

32.05 ± 0.91

32.50 ± 0.92

0.732

40.58 ± 1.55

46.60 ± 1.66

0.011*

55.89 ± 3.87

53.23 ± 2.50

0.570

ALT (U/L)

19.50 ± 0.90

25.75 ± 1.51

< 0.001*

49.28 ± 2.36

60.05 ± 4.80

0.027*

60.11 ± 5.64

70.91 ± 4.39

0.040*

AST (U/L)

19.42 ± 0.85

29.63 ± 2.11

< 0.001*

49.20 ± 2.94

66.45 ± 6.14

0.010*

65.17 ± 6.66

70.46 ± 5.52

0.046*

T. bilirubin (mg/dl)

0.58 ± 0.03

0.86 ± 0.04

< 0.001*

1.73 ± 0.23

1.84 ± 0.56

0.868

1.72 ± 0.44

1.81 ± 0.19

0.817

Albumin (g/L)

4.25 ± 0.07

3.45 ± 0.08

< 0.001*

3.57 ± 0.30

3.41 ± 0.21

0.666

3.23 ± 0.20

2.89 ± 0.12

0.136

Platelets (109/L)

239.5 ± 7.2

240.7 ± 8.4

0.920

200.2 ± 35.1

143.9 ± 24.5

0.224

245.5 ± 121.5

110.7 ± 13.6

0.025*

AFP (U/L)

1.04 ± 0.08

1.70 ± 0.05

< 0.001*

26.38 ± 3.93

71.04 ± 19.71

0.003*

36.14 ± 4.87

106.96 ± 22.39

0.030*

  1. Variables were expressed as mean ± SEM
  2. aReference values: alanine aminotransferase (ALT) (male up to 41 U/L, female up to 31 U/L); aspartate aminotransferase (AST) (male up to 37 U/L, female up to 31 U/L); total bilirubin (T. bilirubin) up to 1 mg/dL; albumin 3.8‑5.4 g/dL; platelet count 150‑400 ×109/L; alpha fetoprotein (AFP) up to 10 U/L
  3. bGroup I: hepatitis C virus mono-infection; Group II: hepatitis C virus/Helicobacter pylori co-infection
  4. *P < 0.05 is considered significant